LIGHT CHAIN ANALYSIS

This adverse event was reported 24 times

LIGHT CHAIN ANALYSIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 SUTIMLIMAB-JOME 1 0.0031
1 AMPICILLIN SODIUM AND SULBACTAM SODIUM 2 0.0008
2 PYRIDOSTIGMINE BROMIDE 2 0.0003
3 LIDOCAINE PATCH 5% 2 0.0003
4 BAYER ASPIRIN EXTRA STRENGTH 1 0.0003
5 ATOVAQUONE 2 0.0002
6 MEPERIDINE HYDROCHLORIDE 2 0.0002
7 IRON SUCROSE 2 0.0002
8 RIZATRIPTAN BENZOATE 2 0.0002
9 CARBOXYMETHYLCELLULOSE SODIUM 1 0.0002
See all drugs enriched for association with LIGHT CHAIN ANALYSIS

LIGHT CHAIN ANALYSIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Classical Complement Pathway Inhibitor [EPC] 1 0.0031
1 Antimalarial [EPC] 2 0.0002
2 Antiprotozoal [EPC] 2 0.0002
3 Parenteral Iron Replacement [EPC] 2 0.0001
4 Aluminum Complex [EPC] 2 0.0001
5 Alkaloid [EPC] 2 0.0001
6 B Lymphocyte Stimulator-specific Inhibitor [EPC] 2 0.0001
7 Proteasome Inhibitor [EPC] 6 0.0001
8 Muscle Relaxant [EPC] 2 0.0000
9 Tetracycline-class Drug [EPC] 2 0.0000
See all drug classes enriched for association with LIGHT CHAIN ANALYSIS